FZD2 and breast cancer: FZD2 and its ligands Wnt5a/b (Wnt signaling pathway) were elevated in many cancers including breast cancer, and their expression correlated with epithelial–mesenchymal transition (EMT), which is a process that allows cancer cells to infiltrate surrounding tissues and metastasize to distant sites [22].